Terms: = Breast cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Prognosis
157 results:
1. [Guideline for the management path and quality control of breast cancer prevention and treatment in China's counties (2023 edition)].
;
Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):1-18. PubMed ID: 38246777
[TBL] [Abstract] [Full Text] [Related]
2. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
Du J; Yang Q; Sun Y; Shi P; Xu H; Chen X; Dong T; Shi W; Wang Y; Song Z; Shang X; Tian X
Front Endocrinol (Lausanne); 2023; 14():1288527. PubMed ID: 38047112
[TBL] [Abstract] [Full Text] [Related]
3. HER2-positive advanced biliary tract cancer responds to second-line pyrotinib therapy: a case report.
Liu L; Chen Y; Zhu X; Zhao L; Chen B
Anticancer Drugs; 2024 Mar; 35(3):298-301. PubMed ID: 38037743
[TBL] [Abstract] [Full Text] [Related]
4. cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors.
He S; Xia C; Li H; Cao M; Yang F; Yan X; Zhang S; Teng Y; Li Q; Chen W
Sci China Life Sci; 2024 Jan; 67(1):122-131. PubMed ID: 37755589
[TBL] [Abstract] [Full Text] [Related]
5. Risk factors and survival prediction of young breast cancer patients with liver metastases: a population-based study.
Pu CC; Yin L; Yan JM
Front Endocrinol (Lausanne); 2023; 14():1158759. PubMed ID: 37424855
[TBL] [Abstract] [Full Text] [Related]
6. Investigating Genetic Factors and the Effect of Refined Multidisciplinary Clinical Management on the Quality of Life and Perceived Control Level of breast cancer Patients undergoing Surgery and its Morphological Diagnosis Parameters.
Yu L; Dong R; Lv Y; Shi S; Xue H; Miao J; Yu J
Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):53-59. PubMed ID: 37329548
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of breast cancer Family History, Estrogen Receptor Status, and breast cancer Outcomes in Sweden.
Zhang Y; Wang QL; Zeng E; He W; Czene K
JAMA Netw Open; 2023 Jun; 6(6):e2318053. PubMed ID: 37310740
[TBL] [Abstract] [Full Text] [Related]
8. Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma.
Saeki I; Suehiro Y; Yamauchi Y; Hoshida T; Tanabe N; Oono T; Kawamoto D; Nishimura T; Matsumoto T; Ishikawa T; Shimokawa M; Tamori A; Kawada N; Tamai Y; Iwasa M; Nakagawa H; Nagano H; Takami T; Yamasaki T
Hepatol Int; 2023 Oct; 17(5):1289-1299. PubMed ID: 37186217
[TBL] [Abstract] [Full Text] [Related]
9. Interaction of reproductive tract infections with estrogen exposure on breast cancer risk and prognosis.
Li Y; Gan X; Liang Z; Ye H; Lin Y; Liu Q; Xie X; Tang L; Ren Z
BMC Womens Health; 2023 May; 23(1):238. PubMed ID: 37158842
[TBL] [Abstract] [Full Text] [Related]
10. Targeted treatment of triple-negative-breast cancer through pH-triggered tumour associated macrophages using smart theranostic nanoformulations.
Scialla S; Hanafy MS; Wang JL; Genicio N; Costa Da Silva M; Costa M; Oliveira-Pinto S; Baltazar F; Gallo J; Cui Z; Bañobre-López M
Int J Pharm; 2023 Feb; 632():122575. PubMed ID: 36603672
[TBL] [Abstract] [Full Text] [Related]
11. Rapid metabolomic screening of cancer cells via high-throughput static droplet microfluidics.
Radfar P; Ding L; de la Fuente LR; Aboulkheyr H; Gallego-Ortega D; Warkiani ME
Biosens Bioelectron; 2023 Mar; 223():114966. PubMed ID: 36580816
[TBL] [Abstract] [Full Text] [Related]
12. Impact of platinum-based chemotherapy on the prognosis of early triple-negative breast cancer: a systematic review and meta-analysis.
Zhao F; Shen G; Dong Q; Xin Y; Huo X; Wang M; Liu Z; Zhao Y; Ren D; Xie Q; Liu Z; Li Z; Gao L; Du F; Zhao J
Clin Exp Med; 2023 Oct; 23(6):2025-2040. PubMed ID: 36422737
[TBL] [Abstract] [Full Text] [Related]
13. LncRNAs as biomarkers for predicting radioresistance and survival in cancer: a meta-analysis.
Xie Y; Han J; Xie K; Gou Q
Sci Rep; 2022 Nov; 12(1):18494. PubMed ID: 36323697
[TBL] [Abstract] [Full Text] [Related]
14. SENTINEL LYMPH NODES DETECTION METHOD IN breast cancer.
Nikitenko R
Georgian Med News; 2022; (328-329):122-126. PubMed ID: 36318855
[TBL] [Abstract] [Full Text] [Related]
15. Cost-Effectiveness of Pyrotinib Plus Capecitabine versus Lapatinib Plus Capecitabine for the Treatment of HER2-Positive Metastatic breast cancer in China: A Scenario Analysis of Health Insurance Coverage.
Bao Y; Zhang Z; He X; Cai L; Wang X; Li X
Curr Oncol; 2022 Aug; 29(9):6053-6067. PubMed ID: 36135045
[TBL] [Abstract] [Full Text] [Related]
16. Assessment of cell-free DNA (cfDNA) concentrations in the perioperative period can predict risk of recurrence in patients with non-metastatic breast cancer.
Hassan F; Wang JH; Cullinane C; Ita M; Corrigan M; O'Leary DP; Redmond HP
Surg Oncol; 2022 Jun; 42():101753. PubMed ID: 35594723
[TBL] [Abstract] [Full Text] [Related]
17. Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced breast cancer: Results From the Randomized Phase III EMERALD Trial.
Bidard FC; Kaklamani VG; Neven P; Streich G; Montero AJ; Forget F; Mouret-Reynier MA; Sohn JH; Taylor D; Harnden KK; Khong H; Kocsis J; Dalenc F; Dillon PM; Babu S; Waters S; Deleu I; García Sáenz JA; Bria E; Cazzaniga M; Lu J; Aftimos P; Cortés J; Liu S; Tonini G; Laurent D; Habboubi N; Conlan MG; Bardia A
J Clin Oncol; 2022 Oct; 40(28):3246-3256. PubMed ID: 35584336
[TBL] [Abstract] [Full Text] [Related]
18. The Role of Nutritional Status, Gastrointestinal Peptides, and Endocannabinoids in the prognosis and Treatment of Children with cancer.
Schab M; Skoczen S
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563548
[TBL] [Abstract] [Full Text] [Related]
19. Clinical Significance of Expression of Immunoadjuvant Molecules (LAG-3, TIM-3, OX-40) in Neoadjuvant Chemotherapy for breast cancer.
Asano Y; Kashiwagi S; Takada K; Ishihara S; Goto W; Morisaki T; Shibutani M; Tanaka H; Hirakawa K; Ohira M
Anticancer Res; 2022 Jan; 42(1):125-136. PubMed ID: 34969718
[TBL] [Abstract] [Full Text] [Related]
20. Low Expression of Long Noncoding RNA SLC26A4 Antisense RNA 1 Is an Independent Prognostic Biomarker and Correlate of Immune Infiltrates in breast cancer.
Yi W; Shen H; Sun D; Xu Y; Feng Y; Li D; Wang C
Med Sci Monit; 2021 Dec; 27():e934522. PubMed ID: 34880202
[TBL] [Abstract] [Full Text] [Related]
[Next]
